Amidst the 27th annual meeting of the Latin American Society of Interventional Cardiology and the annual meeting of the Mexican Society of Interventional Cardiology, the 12th edition of our course for fellow interventionists ProEducar was held. The course – directed by Dr. Leandro Lasave (ARG) and codirected by Drs. Gabriel Maluenda (CHL), Guering Eid Lidt...
IMPORTANT INFORMATION FOR ALL CONGRESS ATTENDEES! Only 1 day left before the largest interventional cardiology event in Latin America starts! Consequently, we want you to have some important information about it. Download the scientific program in PDF format Download the full program to your cell phone and enjoy all content related to our event. Download...
Intervention of chronic total occlusions (CTO) through angioplasty (PCI) can cause complications, even in highly experienced centers. Plenty has been written on the probability of success for the treatment of CTOs using scores such as CL-SCORE, J-CTO, ORA, E-CTO, CASTLE-CTO, etc. (some of which are usually used when preparing these cases). However, besides estimating success...
READ THE PRELIMINARY SCENTIFIC PROGRAM At SOLACI-SOCIME 2022 you will be able to enjoy -throughout 3 days – simultaneous activities in 4 rooms, a room of edited cases and free topics, and a digital plaza of innovations. In addition, we will be featuring our traditional satellite ProEducar, Pediatrics and Nurses and Technicians symposia Register now...
In the last few years, we have seen significant growth of chronic total occlusion (CTO) percutaneous intervention, which has also been considered for patients with viable territory that remain symptomatic. Experienced centers present successful CTO intervention rates close to 90%, especially with a hybrid approach. However, it is still a complex procedure, and target vessel...
Currently, the number of nonagenarian patients undergoing angioplasty (whether elective, urgent or emergency) has increased. This population is linked to more comorbidities and has barely been included in most randomized studies or registries. As such, we do not have robust evidence on this group. Researchers conducted an analysis of the J-PCI OUTCOME Registry, in which...
+25 INTERNATIONAL GUESTS WILL BE SHARING THEIR KNOWLEDGE AT SOLACI-SOCIME 2022 Why is SOLACI-SOCIME 2022 an unmissable event for Latin American interventional cardiologists? Because it is the perfect place for the main experts and opinion leaders in the field to meet. This year, over 25 guests from Europe, Asia and the United States will be...
REGISTER TO THE CONGRESS VIRTUAL SESSIONS This year, SOLACI-SOCIME 2022 will stream live all scientific sessions at the Main Arena from August 4-6. Furthermore, all content will be available on demand for a month after the event is over. This way, you will be able to take part in the largest meeting of interventional cardiologists in Latin America from...
LAST DAYS TO SIGN UP WITH 15% OFF We are a little less than one month away from the most relevant meeting of interventional cardiology in Latin America. This year we celebrate the long-awaited return to our face to face meetings. This is why we have prepared an innovative scientific program with challenging live and edited...
At present, percutaneous coronary intervention (PCI) is the most common coronary revascularization strategy. One of its benefits is that patients can be safely discharged when procedures are programed, which helps decompress hospital capacity. However, this strategy has not been validated for acute coronary syndromes; the evidence gathered for non-ST elevation ACS is far from robust,...